Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 10351-10400 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06597006
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
PHASE3
Recruiting
9 participants
Started: Feb 28, 2025 · Completed: Apr 15, 2029
1 condition
1 sponsor
15 locations
NCT06894212
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
PHASE3
Recruiting
522 participants
Started: Feb 28, 2025 · Completed: Oct 29, 2026
1 condition
1 sponsor
35 locations
NCT06664528
Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies
N/A
Recruiting
300 participants
Started: Feb 28, 2025 · Completed: Dec 15, 2028
2 conditions
1 sponsor
1 location
NCT06858189
Promoting Active Therapy: Path to Wellness
PHASE2
Recruiting
60 participants
Started: Feb 28, 2025 · Completed: May 31, 2026
5 conditions
2 sponsors
1 location
NCT06819436
Effect of Dexamethasone on Post-spinal Hypotension
PHASE4
Recruiting
170 participants
Started: Feb 28, 2025 · Completed: May 31, 2025
3 conditions
1 sponsor
1 location
NCT06886516
Apixaban in Thrombocytopenia
EARLY_PHASE1
Recruiting
30 participants
Started: Feb 28, 2025 · Completed: Jul 1, 2028
4 conditions
1 sponsor
1 location
NCT06523621
Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel
PHASE2
Recruiting
50 participants
Started: Feb 28, 2025 · Completed: Nov 30, 2027
1 condition
3 sponsors
2 locations
NCT06685237
Copenhagen Heart Failure With Preserved Ejection Fraction
N/A
Recruiting
5,000 participants
Started: Feb 28, 2025 · Completed: Mar 28, 2026
1 condition
1 sponsor
1 location
NCT06848465
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
PHASE1
Recruiting
9 participants
Started: Feb 28, 2025 · Completed: Nov 30, 2027
3 conditions
1 sponsor
2 locations
NCT06867016
Effects of Bidomain Cognitive and Aerobic Training on Cognitive Functioning in Mild Cognitive Impairment.
NA
Recruiting
44 participants
Started: Feb 28, 2025 · Completed: Aug 28, 2025
1 condition
1 sponsor
1 location
NCT06863350
Percutaneous Repair for Drug - Resistant Epilepsy by Intervention of Closing the Patent Foramen Ovale(PREDICT-PFO Trial)
NA
Recruiting
180 participants
Started: Feb 28, 2025 · Completed: Jun 1, 2027
1 condition
1 sponsor
1 location
NCT06771284
Problem Behavior Assessment and Intervention in IDEA Part C Services
NA
Recruiting
9 participants
Started: Feb 28, 2025 · Completed: May 31, 2025
3 conditions
2 sponsors
1 location
NCT06816771
Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents
PHASE2
Recruiting
38 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06633562
A Study to Test the Effects of Nezavist At Different Doses in Healthy Adults
PHASE1
Recruiting
32 participants
Started: Feb 28, 2025 · Completed: Dec 1, 2025
3 conditions
2 sponsors
1 location
NCT06703060
A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women
NA
Recruiting
300 participants
Started: Feb 28, 2025 · Completed: Feb 29, 2028
4 conditions
2 sponsors
1 location
NCT06736717
Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
PHASE1/PHASE2
Recruiting
21 participants
Started: Feb 28, 2025 · Completed: Jan 31, 2027
1 condition
2 sponsors
1 location
NCT06736925
Omega-3 Fatty Acids and Subconcussive Head Impacts
NA
Recruiting
208 participants
Started: Feb 28, 2025 · Completed: May 31, 2029
2 conditions
2 sponsors
1 location
NCT07075159
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
NA
Recruiting
20 participants
Started: Feb 28, 2025 · Completed: Mar 1, 2026
3 conditions
1 sponsor
1 location
NCT06762782
Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery
PHASE2
Recruiting
276 participants
Started: Feb 28, 2025 · Completed: Oct 31, 2027
2 conditions
11 sponsors
1 location
NCT06792071
Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders
NA
Recruiting
18 participants
Started: Feb 28, 2025 · Completed: Jul 31, 2027
4 conditions
4 sponsors
1 location
NCT06840249
Pediatric Vascular Trauma
N/A
Recruiting
75 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT06774534
SerpinB3 Expression, PAR2 and SCCA-PD Polymorphism in Acute Respiratory Distress Syndrome
N/A
Recruiting
40 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2030
2 conditions
1 sponsor
1 location
NCT06735053
Impact of Virtual Reality Physiotherapy on Multiple Sclerosis Patients
NA
Recruiting
26 participants
Started: Feb 28, 2025 · Completed: Jul 31, 2025
1 condition
1 sponsor
2 locations
NCT06768749
The Impact of Melatonin Lotion on Sleep and Mental Health
NA
Recruiting
60 participants
Started: Feb 28, 2025 · Completed: Apr 1, 2028
2 conditions
1 sponsor
1 location
NCT06812390
Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites
PHASE2
Recruiting
20 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2027
2 conditions
2 sponsors
1 location
NCT06761924
Predicting Ultrasound-Guided Thoracic PVB Success in Herpetic Neuralgia
NA
Recruiting
140 participants
Started: Feb 28, 2025 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT06658145
Safety and Efficacy of Using a Novel Full Visual Access Platform System in Transvaginal Hysterectomy
NA
Recruiting
94 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT06867393
Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects
PHASE1
Recruiting
52 participants
Started: Feb 28, 2025 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT06773312
BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.
PHASE1
Recruiting
80 participants
Started: Feb 28, 2025 · Completed: Apr 30, 2027
2 conditions
2 sponsors
1 location
NCT07125248
Outcomes of a Single Chest Drain vs Two Drains
NA
Recruiting
68 participants
Started: Feb 28, 2025 · Completed: Sep 10, 2025
3 conditions
1 sponsor
1 location
NCT06830642
Study of the Oral Treatment MTR-601 in Cervical Dystonia
PHASE2
Recruiting
80 participants
Started: Feb 28, 2025 · Completed: Aug 3, 2026
1 condition
1 sponsor
17 locations
NCT06977009
Influence of Occlusal Reduction on Endodontic Postoperative Pain
NA
Recruiting
60 participants
Started: Feb 28, 2025 · Completed: Jul 20, 2025
1 condition
1 sponsor
1 location
NCT06856577
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
PHASE3
Recruiting
284 participants
Started: Feb 28, 2025 · Completed: Mar 25, 2030
2 conditions
1 sponsor
79 locations
NCT06921902
Glycemic Metrics and Patterns in People With and Without Prediabetes
N/A
Recruiting
2,000 participants
Started: Feb 28, 2025 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT06753370
Experiences of Managing Sleep Disordered Breathing in Children With Cerebral Palsy.
N/A
Recruiting
20 participants
Started: Feb 28, 2025 · Completed: Aug 31, 2026
3 conditions
1 sponsor
2 locations
NCT06922955
A Prospective Study Comparing VivAer to Alternative Surgical Procedures to Treat Nasal Airway Obstruction in Patients With Nasal Valve Dysfunction.
N/A
Recruiting
400 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2027
1 condition
1 sponsor
35 locations
NCT06797024
JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
NA
Recruiting
20 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT04211753
Effectiveness and Security Testing of a Mobile App (B·RIGHT) for Emotional Crisis in Borderline Personality Disorder
NA
Recruiting
80 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06831929
HPV Ends Here: Increasing Uptake of the HPV Vaccine
NA
Recruiting
2,232 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT06201676
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
PHASE4
Recruiting
458 participants
Started: Feb 28, 2025 · Completed: Aug 31, 2027
2 conditions
2 sponsors
2 locations
NCT06812988
Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule
PHASE2
Recruiting
84 participants
Started: Feb 28, 2025 · Completed: Sep 13, 2028
1 condition
1 sponsor
23 locations
NCT06764316
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
PHASE1
Recruiting
148 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2033
1 condition
1 sponsor
10 locations
NCT06778863
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
PHASE1
Recruiting
90 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2028
11 conditions
1 sponsor
15 locations
NCT06768476
CART123 + Ruxolitinib in Relapsed/Refractory AML
PHASE1
Recruiting
12 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2045
2 conditions
2 sponsors
1 location
NCT06673043
Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus
N/A
Recruiting
100 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2028
1 condition
1 sponsor
11 locations
NCT06852209
Training Cognition With Neurofeedback After Stroke
NA
Recruiting
20 participants
Started: Feb 28, 2025 · Completed: Nov 28, 2026
2 conditions
1 sponsor
1 location
NCT06923371
Moms and Babies Health and Well-being
NA
Recruiting
1,250 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT06858696
A Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic Function
PHASE1
Recruiting
48 participants
Started: Feb 28, 2025 · Completed: Apr 30, 2026
1 condition
1 sponsor
4 locations
NCT06942416
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
PHASE2
Recruiting
36 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2028
3 conditions
1 sponsor
1 location
NCT06610266
Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia
PHASE4
Recruiting
400 participants
Started: Feb 28, 2025 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
205
206
207
208
209
210
211
More pages
1333
Next